Condition Overview

Lung Diseases

Support for named pulmonary diagnoses: idiopathic pulmonary fibrosis, bronchiectasis, post-COVID pulmonary sequelae, and refractory asthma, always alongside your pulmonologist.

Book a Consultation Am I a Candidate?

or call (818) 938-9023

Cellular artwork for Lung Diseases Personalized review, grounded in your health history.
Overview

Understanding This Condition

Lung disease is a broad category, not a single diagnosis. Asthma, pulmonary fibrosis, bronchiectasis, sarcoidosis, chronic infections, and other conditions affect the lungs in different ways and require different testing and treatment. If you have new or worsening shortness of breath, chest pain, coughing up blood, a fever with breathlessness, or an oxygen reading that has dropped, call 911 or go to the nearest emergency department rather than booking a consultation.

Because the causes and risks vary, any discussion must begin with a confirmed diagnosis and current pulmonary care. The conditions this group currently covers are idiopathic pulmonary fibrosis, bronchiectasis, post-COVID pulmonary sequelae, and refractory asthma. Cellular and regenerative approaches are being studied in selected conditions, but they are not established general treatment for lung disease. The FDA warns that regenerative products promoted for pulmonary conditions may be unapproved.

Our consultation reviews your diagnosis, current stability, respiratory medication, oxygen needs, recent testing, and goals. A licensed provider explains the limits of the evidence and decides whether any supportive assessment is appropriate. Many lung conditions will not be eligible.

If your diagnosis is chronic obstructive pulmonary disease, start on our COPD page. If your symptoms began after a COVID infection, start on Long COVID Supportive Care.

Possibilities

Potential Benefits

A lung-health consultation may help you:

  • A structured review of your specific pulmonary diagnosis, recent testing, and current respiratory care
  • A plain account of why no regenerative product is approved as a general treatment for lung disease
  • Screening for factors that affect eligibility, including stability, oxygen needs, and active infection
  • Questions to discuss with your pulmonologist
  • A practical next step if a licensed provider recommends further assessment
Considerations

Who May Benefit

A lung-health assessment may make sense for people including:

  • Adults with a confirmed chronic lung diagnosis who remain under pulmonary care
  • People whose condition is clinically stable enough for a nonurgent consultation
  • Individuals seeking an evidence-aware discussion of emerging research
  • People able to share recent pulmonary testing and medication information
  • Adults who understand that established respiratory care must continue
Related Care

Therapies a Provider May Consider

Every option is reviewed individually after your history, current care, and goals are understood.

  • Physician Guided

Exosome Therapy

Exosome therapy works with the signaling vesicles your cells already use to communicate. Studied for recovery, skin quality and healthy aging, and always planned by a licensed provider.

Learn More about Exosome Therapy
  • Physician Guided

NAD+ Therapy

NAD+ is the coenzyme your cells use to turn food into energy, and levels fall with age. A leading choice for support with energy, mental clarity and recovery.

Learn More about NAD+ Therapy
  • Physician Guided

MUSE Cell Therapy

A stress enduring cell type able to develop into many tissue types. Explored for healthy aging, recovery and whole body cellular wellness, always guided by clinical review.

Learn More about MUSE Cell Therapy
  • Physician Guided

Stem Cell Therapy

The body's own building and repair cells, and the foundation of regenerative medicine. Explored for recovery, mobility and healthy aging through physician guided planning.

Learn More about Stem Cell Therapy
Evidence

What the Research Looks At

Lung diseases differ substantially in cause, severity, and established treatment. Regenerative products are not approved as a general treatment for pulmonary conditions. The references below provide lung-health context, the FDA warning, and registered-study information.

  1. Lung Health Basics National Heart, Lung, and Blood Institute, NIH
  2. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes U.S. Food and Drug Administration
  3. Registered clinical trials related to Lung Disease ClinicalTrials.gov, U.S. National Library of Medicine
Your Next Step

Start With an Assessment

Every visit begins with a consultation and a medical screening. A licensed provider decides what, if anything, is appropriate for you.

Book a Consultation

or call (818) 938-9023

Terms you may hear when discussing lung disease

Because this group covers several different diagnoses, the vocabulary varies. These are the terms that come up most often in pulmonary care and in the records a provider here will ask to see.

  • Pulmonary function tests. A set of breathing tests, including spirometry, lung volumes and gas transfer, that measure how well the lungs move air and oxygen. They are the baseline your pulmonologist uses to follow the condition over time.
  • Idiopathic pulmonary fibrosis. Progressive scarring of the lung tissue with no identified cause. It is diagnosed and managed by a pulmonologist, often with a specialist interstitial lung disease team.
  • Bronchiectasis. Permanent widening and damage of the airways, which makes them prone to mucus build-up and repeated infection. Airway clearance and infection management are part of established care.
  • High-resolution CT. A detailed CT scan of the lungs used to characterize scarring, airway damage and other changes that a chest X-ray cannot show.

A licensed provider reviews your diagnosis, current stability, respiratory medication, oxygen needs and recent testing before deciding whether anything here is appropriate to consider alongside your pulmonary care. Nothing offered is a treatment for any lung disease.

Related conditions in this care area: COPD. If your symptoms began after a COVID infection, see Long COVID Supportive Care. Back to Respiratory Support.

Lung Diseases

Frequently Asked Questions

It depends entirely on the diagnosis. Lung conditions differ substantially in cause, severity, and established treatment, and no regenerative product is approved as a general treatment for any of them. A consultation begins with your confirmed diagnosis and your current pulmonary care. Many conditions will not be eligible.
No. We do not take over diagnosis, disease management, rehabilitation, or prescribed medication. Anything discussed here sits alongside the care provided by your existing clinical team.
This group currently covers idiopathic pulmonary fibrosis, bronchiectasis, post-COVID pulmonary sequelae, and refractory asthma. A confirmed diagnosis from a pulmonologist comes first, and eligibility is still decided case by case. Most enquiries in this group do not proceed past screening.
An unconfirmed diagnosis, unstable breathing, active infection, oxygen dependence, or a condition that is not currently managed by a pulmonologist. Being told that no further step is appropriate is a normal outcome of an honest assessment, and in this group it is the usual one.
Hitech Regen serves Southern California. Availability and suitability are discussed during the consultation before any visit is scheduled.
Cost is discussed after a licensed provider determines whether anything is appropriate to consider. We do not quote a condition-specific plan before the assessment.
It is a general page. What matters is your specific diagnosis and who is managing it, and that is what a licensed provider reviews at the consultation before deciding whether anything is appropriate.
No. We do not manage lung disease. Those conditions are managed by a pulmonologist, and anything discussed here sits alongside that care.
We make no claim of that kind. Nothing offered here is a cure and no product we work with is FDA approved for lung disease.
Recent pulmonary function tests, recent imaging and your current medication list, as ordered by your own clinician. The provider's review is only as good as the records in front of it.
Book a Consultation